9:35 am

Session 2: Scientific Challenges and Opportunities: Preclinical Issues in Codevelopment
Moderator: James Zwiebel, National Cancer Institute

   
 

Perspectives from the National Cancer Institute
• James Doroshow, National Cancer Institute

   
 

Perspectives from Academia
• David Stern, Yale University
• Carl June, University of Pennsylvania

   
 

Perspectives from Industry
• Kurt Bachman, GlaxoSmithKline

   
 

Panel Discussion (60 minutes) Includes speakers and
• Haleh Saber, Food and Drug Administration
• Robert Iannone, Merck
• Michael Caligiuri, OSU Comprehensive Cancer Center

   
12:00 pm Lunch
   
1:00 pm

Session 3: Scientific Challenges and Opportunities: Clinical Issues in Codevelopment
Moderator: Roy Herbst, Yale Cancer Center

   
 

Perspectives from the National Cancer Institute
• Helen Chen, National Cancer Institute

   
 

Perspectives from Academia
• Patricia LoRusso, Barbara Ann Karmanos Cancer Institute

   
 

Perspectives from Industry
• Stuart Lutzker, Genentech

   
 

Perspectives on Trial Design and Statistical Issues
• Donald Berry, MD Anderson Cancer Center
• Larry Rubinstein, National Cancer Institute



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement